Ordering from the Americas?Switch to the US store
We don't ship to your country yet. We ship across Europe and the Americas. You can keep browsing.

Peptency Academy · Compound

Kisspeptin-10 (metastin 45-54)

Kisspeptin-10 is a 10 residue peptide with the sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe and an amidated C-terminus. The catalog chemistry record also lists it as metastin (45-54). Source sentencePubChem title: Kisspeptin-10. Catalog chemistry record: name Kisspeptin-10, also known as Metastin (45-54), sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, length 10.1 PubChem CID 252402972 Peptency catalog chemistry record, Kisspeptin-10 Kisspeptins of 54, 14 and 13 amino acids were isolated from human placenta as natural agonists of the orphan receptor GPR54, and they share an RF-amide C terminus. Source sentencePubMed title: "The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54." Measured: isolation of kisspeptins from human placenta as ligands of GPR54, with receptor binding and signalling in cells.3 J Biol Chem 2001 PubChem records kisspeptin-10 under CID 25240297: formula C63H83N17O14, about 1302.4 Da, CAS 374675-21-5. Source sentenceTitle: Kisspeptin-10; MolecularFormula: C63H83N17O14; MolecularWeight: 1302.4; CAS: 374675-21-51 PubChem CID 25240297

Research at a glance

Most human model studied
No primary study mapped
Studies reviewed
None mapped yet
Registered trials
0
EMA
No authorisation found
WADA
Named in a prohibited class

Status records

Version 1Edited Evidence through 12 sources

Regulatory content shown for: EU and UK.

Peptide, 10 residues, C-terminal amide

  • Catalog recordKisspeptin-1010 residuesabout 1302.4 DaSource sentenceTitle: Kisspeptin-10; MolecularFormula: C63H83N17O14; MolecularWeight: 1302.4; CAS: 374675-21-51 PubChem CID 25240297

Known, not known, contested

Known

  • The formula computed from the catalog sequence, C63H83N17O14, matches the formula PubChem records, and PubChem confirms the CAS number 374675-21-5 for CID 25240297. Source sentenceCatalog chemistry record cross check (5 Oct 2026): formulaFromSequence C63H83N17O14; PubChem formula C63H83N17O14; casConfirmedByPubChem true.1 PubChem CID 252402972 Peptency catalog chemistry record, Kisspeptin-10
  • A 2001 study in Nature identified the peptide encoded by the KiSS-1 gene as the ligand of an orphan G-protein-coupled receptor and measured receptor activation. Source sentencePubMed title: "Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor." Measured: identified the KiSS-1 gene product peptide as the ligand of an orphan G-protein-coupled receptor and measured receptor activation.4 Nature 2001
  • A 2001 study cloned the human receptor AXOR12 (GPR54) and measured its activation by peptides derived from KiSS-1. Source sentencePubMed title: "AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1." Measured: cloned the human receptor AXOR12 (GPR54) and showed its activation by KiSS-1 derived peptides.5 J Biol Chem 2001
  • A 2003 genetic study in a human family and in mice linked the GPR54 gene to the onset of puberty. Source sentencePubMed title: "The GPR54 gene as a regulator of puberty." Measured: genetic study in a human family and in mice linking GPR54 to the onset of puberty.6 N Engl J Med 2003

Not known

Contested

Nothing listed yet.

Chemistry: Kisspeptin-10 as PubChem CID 25240297 records it

Sequence
YNWNSFGLRF
Length
10 residues
Modifications
C-terminal amide (Phe10-NH2)
Formula
C63H83N17O14
Average mass
1302.4 Da
CAS
374675-21-5
PubChem CID
25240297
Synonyms
Metastin (45-54)
Salt form
No salt form stated in the record
Checked 5 October 2026 1 PubChem CID 25240297

Sequence

YNWNSFGLRF

Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, the 10 residues of Kisspeptin-10 as the catalog record gives them.

Published literature

  • On 5 Oct 2026 PubMed held 333 records matching Kisspeptin-10 by title and abstract, of which 12 carry the clinical trial publication type and 14 the review type. This page reads 4 of them. Source sentencePubMed record count for the query ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab] OR "kisspeptin10"[tiab] OR "metastin 45-54"[tiab]): 333; with clinical trial[pt]: 12; with review[pt]: 14.9 PubMed search for Kisspeptin-10, 5 October 2026

Studies

  1. In vitro or ex vivoJ Biol Chem 2001

    Isolation of kisspeptins from human placenta as ligands of GPR54, with receptor binding and signalling in cells.

    Design
    Receptor biology
    Population or model
    human placenta extract and receptor expressing cells
    Molecule
    Kisspeptins of 54, 14 and 13 amino acids related form

    PubMed 11457843DOI

  2. In vitro or ex vivoNature 2001

    Identified the KiSS-1 gene product peptide as the ligand of an orphan G-protein-coupled receptor and measured receptor activation.

    Design
    Receptor biology
    Population or model
    orphan G-protein-coupled receptor in cells
    Molecule
    KiSS-1 gene product peptide related form

    PubMed 11385580DOI

  3. In vitro or ex vivoJ Biol Chem 2001

    Cloned the human receptor AXOR12 (GPR54) and showed its activation by KiSS-1 derived peptides.

    Design
    Receptor biology
    Population or model
    cloned human receptor AXOR12 (GPR54)
    Molecule
    KiSS-1 derived peptides related form

    PubMed 11387329DOI

  4. Human, uncontrolledN Engl J Med 2003

    Genetic study in a human family and in mice linking GPR54 to the onset of puberty.

    Design
    Human genetics and animal study
    Population or model
    a human family and mice
    Molecule
    The GPR54 gene, not a peptide different molecule

    PubMed 14573733DOI

Receptor discovery and genetics studies

  • Receptor studies from 2001 isolated kisspeptins from human placenta, identified the KiSS-1 gene product peptide as a receptor ligand, and cloned the human receptor AXOR12 (GPR54). Source sentenceMeasured per the PubMed records: isolation of kisspeptins from human placenta; identification of the KiSS-1 peptide as ligand of an orphan G-protein-coupled receptor; cloning of AXOR12 (GPR54) and its activation by KiSS-1 derived peptides.3 J Biol Chem 20014 Nature 20015 J Biol Chem 2001
  • A 2003 study in a human family and in mice examined the GPR54 gene in relation to the onset of puberty. Source sentenceMeasured: genetic study in a human family and in mice linking GPR54 to the onset of puberty.6 N Engl J Med 2003

Status matrix

  • EMA

    No authorisation found 8 EMA medicines data, 5 October 2026

    No centrally authorised procedure in the EMA medicines data names kisspeptin

    Checked 5 October 2026

  • MHRA

    The exact name returns 5 MHRA Products documents that mention it in their text; none was assessed as a product with it as an active substance

    Checked 5 October 2026

  • WADA

    Named in a prohibited class 11 WADA Prohibited List 2026

    S2.2.1: names kisspeptin; the list text reads kisspeptin and its agonist analogues

    List version: 2026In force from 1 January 2026Checked 5 October 2026

European Union: EMA records

EU

  • No centrally authorised procedure in the EMA medicines data of 5 Oct 2026 names kisspeptin as an active substance. National authorisations are not in that dataset. Source sentenceEMA medicines JSON report, snapshot 2026-10-05T06:02:03Z: 0 procedures for kisspeptin; control lookup (semaglutide): 5 procedures.8 EMA medicines data, 5 October 2026

United Kingdom: MHRA records

UK

  • The exact name kisspeptin returns 5 MHRA Products documents on 5 Oct 2026. They mention the name in their text and were not assessed as products with it as an active substance. Source sentenceMHRA Products search for the exact name "kisspeptin" over SmPC, PIL and PAR documents: 5 documents; control lookup (semaglutide): 271 documents.10 MHRA Products search for kisspeptin, 5 October 2026

Sport anti-doping list

International

  • The WADA 2026 Prohibited List, in force from 1 Jan 2026, names kisspeptin under S2.2.1. A WADA entry is a sporting rule, not a statement about legality outside sport. Source sentence• kisspeptin and its agonist analogues; section S2.2.1: Testosterone-stimulating peptides in males including, but not limited to:11 WADA Prohibited List 2026

Registry records

  • On 5 Oct 2026 ClinicalTrials.gov listed 5 registered studies for the names kisspeptin-10 and kisspeptin 10, all of them interventional. Phases as registered: PHASE3 (3), PHASE1 (2). Lead sponsors as registered: Quaid-e-Azam University (2); Stephanie B. Seminara, MD (1); Massachusetts General Hospital (1). Source sentencequery.intr kisspeptin-10 or kisspeptin 10: registered 5, interventional 5, phases {"PHASE3": 3, "PHASE1": 2}, lead sponsors Quaid-e-Azam University (2); Stephanie B. Seminara, MD (1); Massachusetts General Hospital (1).12 ClinicalTrials.gov search for Kisspeptin-10, 5 October 2026

Integrity notes

  • The PubMed records read for the four studies on this page list no correction, retraction or expression of concern (checked 5 Oct 2026). Source sentencePubMed efetch CommentsCorrections for PMIDs 11457843, 11385580, 11387329 and 14573733: none of type ErratumIn, RetractionIn or ExpressionOfConcernIn.9 PubMed search for Kisspeptin-10, 5 October 2026

Other compounds in the Academy

Chemistry and records

Kisspeptin-10: sequence, mass, CAS and regulatory record in the research library →

Sources

  1. 1PubChem CID 25240297 accessed 5 Oct 2026
  2. 2Peptency catalog chemistry record, Kisspeptin-10 accessed 5 Oct 2026
  3. 3J Biol Chem 2001 accessed 5 Oct 2026
  4. 4Nature 2001 accessed 5 Oct 2026
  5. 5J Biol Chem 2001 accessed 5 Oct 2026
  6. 6N Engl J Med 2003 accessed 5 Oct 2026
  7. 7openFDA Drugs@FDA query for kisspeptin and metastin, 5 October 2026 accessed 5 Oct 2026
  8. 8EMA medicines data, 5 October 2026 accessed 5 Oct 2026
  9. 9PubMed search for Kisspeptin-10, 5 October 2026 accessed 5 Oct 2026
  10. 10MHRA Products search for kisspeptin, 5 October 2026 accessed 5 Oct 2026
  11. 11WADA Prohibited List 2026 accessed 5 Oct 2026
  12. 12ClinicalTrials.gov search for Kisspeptin-10, 5 October 2026 accessed 5 Oct 2026

About this page

Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.

Drafted from the verified research library records and passed the Academy schema, cross reference and wording checks. The seven checker rounds used on the earlier compound pages have not been run on this page.. Version 1, edited 16 November 2026, 12 sources.

Cite this page: Peptency Academy. Kisspeptin-10: sequence, studies and status. Version 1./eu/academy/compounds/kisspeptin-10/